Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from Analysts

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has been given a consensus rating of "Hold" by the eighteen ratings firms that are presently covering the company, Marketbeat.com reports. Twelve analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $18.22.

A number of analysts have issued reports on TDOC shares. Truist Financial decreased their target price on Teladoc Health from $23.00 to $17.00 and set a "hold" rating for the company in a research report on Wednesday, March 6th. Piper Sandler decreased their target price on Teladoc Health from $30.00 to $25.00 and set an "overweight" rating for the company in a research report on Wednesday, February 21st. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Friday, April 26th. Evercore ISI reduced their price target on Teladoc Health from $15.00 to $14.00 and set an "in-line" rating for the company in a research report on Friday, April 26th. Finally, Citigroup reduced their price target on Teladoc Health from $21.00 to $19.00 and set a "neutral" rating for the company in a research report on Wednesday, February 21st.

Teladoc Health Stock Up 0.8 %

NYSE:TDOC traded up $0.09 on Wednesday, hitting $11.92. The stock had a trading volume of 3,588,793 shares, compared to its average volume of 4,854,590. The business's fifty day moving average is $13.73 and its 200 day moving average is $17.08. The company has a market cap of $2.02 billion, a PE ratio of -8.45 and a beta of 0.97. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health has a 52 week low of $11.67 and a 52 week high of $30.41.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. During the same quarter in the previous year, the company posted ($0.37) EPS. The firm's revenue was up 2.7% on a year-over-year basis. On average, equities research analysts expect that Teladoc Health will post -1.04 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In related news, insider Daniel Trencher sold 6,780 shares of the business's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $98,445.60. Following the transaction, the insider now owns 28,192 shares in the company, valued at approximately $409,347.84. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Teladoc Health news, insider Daniel Trencher sold 6,780 shares of the company's stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $98,445.60. Following the transaction, the insider now owns 28,192 shares in the company, valued at approximately $409,347.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Laizer Kornwasser sold 10,411 shares of the company's stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The disclosure for this sale can be found here. Insiders have sold a total of 137,368 shares of company stock worth $1,968,587 in the last 90 days. Company insiders own 0.95% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently modified their holdings of TDOC. ICA Group Wealth Management LLC purchased a new stake in Teladoc Health in the 4th quarter worth $28,000. Hexagon Capital Partners LLC lifted its holdings in shares of Teladoc Health by 204.4% in the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider's stock valued at $34,000 after acquiring an additional 1,065 shares during the last quarter. RIA Advisory Group LLC bought a new stake in Teladoc Health in the fourth quarter worth about $36,000. GAMMA Investing LLC bought a new stake in Teladoc Health in the fourth quarter worth about $41,000. Finally, Principal Securities Inc. bought a new stake in Teladoc Health in the fourth quarter worth about $45,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.